Cixutumumab (Anti-IGF1R / CD221)
Product Specifications
CAS Number
947687-12-9
Synonyms
IMC-A12
Additionnal Information
Cixutumumab (Anti-IGF1R / CD221) is a humanized monoclonal antibody with high affinity that targets type-1-insulin-like growth factor receptor (IGF-1R) .It shows broad-spectrum anti-tumour activity and can be used in studies of sarcomas, neuroblastoma, wilms tumor, lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer. MW :150 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040204-100 1x 100 µL
Complement C4d (C4D204), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040008-500 1x 500 µL
MAGE A1 (MA454), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470012-100 1x 100 µL
Tyrosinase (T311), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400904-500 1x 500 µL
CD34 (QBEnd/10 + HPCA1/763), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881766-500 1x 500 µL
CD43 (T-Cell Marker) (SPN/1766R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details